Corticosteroid: Clinical Trials

3 trials for Corticosteroid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Terminated 1, Withdrawn 1

Follow Corticosteroid: new trials by email Literature Review of Corticosteroid trials Research Report on Corticosteroid

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment Efficacy of Systemic Corticosteroids in AECOPD Patients With Higher Blood Eosinophil Levels
Prednisone, Placebo - Acute Exacerbation of COPD, Corticosteroid
Phase 4TerminatedCapital Medical University112023-03-052024-08-28
Assessment and Comparison of Efficacy of Intra-Articular PRP and Corticosteroid in First CMC Joint OA Treatment
PRP, Corticosteroid - Thumb Osteoarthritis, Hand Osteoarthritis
Phase 4CompletedAntalya Training and Research Hospital602022-02-012024-10-24
High-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
Methylprednisolone, Tocilizumab - COVID-19 Virus Infection, Cytokine Storm
Phase 4WithdrawnMarmara University2021-02-012021-11-24

Narrower conditions

COVID-19 (1)  ·  Cytokine Release Syndrome (1)  ·  Lung Diseases, Obstructive (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Chronic Disease (1)  ·  Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Nidovirales Infections (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Infections (1)

Interventions

Adrenal Cortex Hormones (2)  ·  Methylprednisolone (1)  ·  Methylprednisolone Acetate (1)  ·  Prednisone (1)  ·  tocilizumab (1)

Sponsors

Antalya Training and Research Hospital (1)  ·  Capital Medical University (1)  ·  Marmara University (1)

Countries

China (1)  ·  Turkey (Türkiye) (1)

Top investigators

Nimet Ezgi Dabak, M.D. (1)  ·  Ruslan Abdullayev (1)  ·  Tong Zhaohui, PhD (1)

Results publications

PMID 37247957